A workshop on pubertal hormone replacement options in the United States

Area of Science:

• Pediatric Endocrinology
• Reproductive Medicine
• Adolescent Health

Background:

• The optimal approach to pubertal hormone replacement therapy (HRT) for both females and males remains an area of clinical uncertainty.
• Hypogonadism in adolescents necessitates timely and effective HRT to ensure proper pubertal development and long-term health outcomes.

Purpose of the Study:

• To conduct a comprehensive review of available hormone replacement options for hypogonadal teenagers.
• To ascertain the current attitudes and clinical practices of pediatric endocrinologists in the United States regarding pubertal induction.

Main Methods:

• A specialized workshop focused on pubertal HRT options was convened during the 2004 Lawson Wilkins Pediatric Endocrine Society meeting.
• A questionnaire survey was administered to workshop attendees to gather data on their approaches and perspectives on inducing puberty.

Main Results:

• The majority of surveyed pediatric endocrinologists reported using conjugated estrogens for hypogonadal girls, prioritizing the attainment of maximal adult height.
• Depot testosterone was the preferred treatment for hypogonadal boys among most respondents, with the primary goals being pubertal development and virilization.

Conclusions:

• The study recommends the utilization of physiological sex hormone replacement to optimize pubertal induction in hypogonadal adolescents.
• Significant discrepancies were identified between US and European pediatric endocrinologists' practices and attitudes concerning HRT for hypogonadal females, highlighting the need for further research.
• The findings underscore the necessity for more extensive studies to establish standardized guidelines for pubertal induction in hypogonadal adolescents.